Drugs Made In America Acquisition (DMIIR) Prepaid Assets (2024 - 2025)

Drugs Made In America Acquisition (DMIIR) reported Prepaid Assets of $25814.0 for Q4 2025, down 39.38% year-over-year from $42580.0 in Q4 2024, and up 72.09% on a QoQ basis from $15000.0 in Q3 2025.

Drugs Made In America Acquisition (DMIIR) has 2 years of Prepaid Assets data on file, last reported at $25814.0 in Q4 2025.

  • Quarterly Prepaid Assets fell 39.38% year-over-year to $25814.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25814.0 (down 39.38% YoY) and the FY2025 annual result came in at $25814.0, down 39.38% from the prior year.
  • Prepaid Assets advanced to $25814.0 in Q4 2025 per DMIIR's latest filing, from $15000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $42580.0 in Q4 2024 and bottomed at $15000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn -
2 Berto Acquisition 316.66 Mn 316.66 Mn -
3 Centurion Acquisition 311.94 Mn 311.94 Mn -
4 Churchill Capital Corp IX 311.36 Mn 311.36 Mn -
5 Agriculture & Natural Solutions Acquisition 301.94 Mn 301.94 Mn -
6 Siddhi Acquisition Corp (Cayman Islands) 286.76 Mn 286.76 Mn -
7 Bold Eagle Acquisition 276.06 Mn 276.06 Mn -
8 Cartesian Growth Corp III 270.68 Mn 270.68 Mn -
9 Oyster Enterprises II Acquisition 266.84 Mn 266.84 Mn -
10 Drugs Made In America Acquisition - - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 25,814.00
Sep 30, 2025 15,000.00
Dec 31, 2024 42,580.00